RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...
Analysts have recently evaluated RBC Bearings and provided 12-month price targets. The average target is $360.6, accompanied by a high estimate of $395.00 and a low estimate of $335.00. Surpassing the ...
Good morning and thank you for joining us for RBC Bearings’ Fiscal Third Quarter 2025 Earnings Call. I am Rob Moffatt, Director of Corporate Development and Investor Relations. And with me on today’s ...